How To Spot a 100% Winner
It wasn’t long ago that I highlighted Planet Labs as a stock with the potential to blast off. At the time it was sitting at $1.90 per share.
Fast forward to the present and Planet Labs has soared well above $4 per share and is now posting gains of over 100%.
So what was it that revealed the hallmarks of a stock about to pop? » Read more about: How To Spot a 100% Winner »
Read More
Why Bitcoin Will Moon
If you’re on the sideline wondering where bitcoin will go, we’re about to demystify it.
Warren Buffett famously described bitcoin as “rat poison squared” and a major reason for that view was the cryptocurrency’s failure to produce cash flows, or anything else really.
Buffett was viewing bitcoin more like an asset than something more elementary,
» Read more about: Why Bitcoin Will Moon »
Read More
Champion Trader vs Cathie Wood: Who Wins?
A battle between a great trader and a prominent money manager has taken place in recent years. Mark Minervini, 2x US trading champion, has taken shots at billion dollar money manager, Cathie Wood of ARK Invest.
His primary critique appears to be based in a rule that he has observed over time. A stock that has fallen 80% can decline by another 50%.
» Read more about: Champion Trader vs Cathie Wood: Who Wins? »
Read More
How Zuckerberg Can Seize The Next Trillion
CEO Mark Zuckerberg doesn’t get as much credit as he may deserve for his ferocity and tenaciousness. As the head of Meta, he is widely viewed as the dorky tech guy who stumbled upon a great idea and just happened to build a big social media business.
The truth is he’s a harsh competitor,
» Read more about: How Zuckerberg Can Seize The Next Trillion »
Read More
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Ivy
Why Did Billionaire with Perfect Track Record Buy This Stock?
ZoomInfo Technologies Inc. (NASDAQ: ZI) might have won over legendary investor Stan Druckenmiller but the market hasn’t been so kind, punishing the stock to the tune of 37% year-to-date.
When management unveiled earnings last quarter, $303.6 million in top line sales failed to ignite enthusiasm given that it represented a 3.3% year-over-year decline.
» Read more about: Why Did Billionaire with Perfect Track Record Buy This Stock? »
Read MoreThe Spotlight
1 Seriously Overlooked Healthcare Stock That Could Soar
Sometimes the seemingly most boring companies in the world produced the most extraordinary returns. One healthcare firm that hasn’t shot up – yet – but which has attracted the attention of a multi-billion dollar fund with a pristine track record may be set to do so.
Better yet, it’s trading close to the estimated price paid by the fund,
» Read more about: 1 Seriously Overlooked Healthcare Stock That Could Soar »
Read MoreThe Daily
Unpacking the Latest Options Trading Trends in Datadog
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and …
» Read more about: Unpacking the Latest Options Trading Trends in Datadog »